--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-26-271115" form_type: "8-K" ticker: "ACH" cik: "0000075252" company_name: "ACCENDRA HEALTH INC/VA/" filed_at: "2026-06-15T20:15:40+00:00" generated_at: "2026-06-15T20:25:58.817160+00:00" event_type: "debt" sentiment: "negative" materiality_score: 0.8 calibrated_materiality_score: 0.8 confidence: "high" source: SEC EDGAR --- # Accendra Health exchanges nearly all outstanding notes for new secured notes at 9%-9.75% rates ## Summary - Approximately 99.9% of 2029 Notes ($478.3M) and 99.2% of 2030 Notes ($547.9M) tendered and accepted early. - Issued $539.25M of 9.000% Senior Secured First Lien Notes due 2032 and $698.0M of 9.75% Senior Secured Second Lien Notes due 2033. - Also issued $326.25M of new money First Lien Notes; entered into new $300M revolving credit facility due 2030. - Outstanding Existing Notes reduced to $363,000 of 2029 Notes and $4.257M of 2030 Notes after cancellation. - Amendments adopted to eliminate most covenants and modify defeasance provisions; credit agreement covenants tightened (leverage <5.5x). ## SEC filing metadata - accession: 0001193125-26-271115 - form_type: 8-K - ticker: ACH - cik: 0000075252 - company_name: ACCENDRA HEALTH INC/VA/ - filed_at: 2026-06-15T20:15:40+00:00 - event_type: debt - sentiment: negative - materiality_score: 0.8 - calibrated_materiality_score: 0.8 - confidence: high - sec_items: 1.01, 2.03, 8.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000119312526271115/0001193125-26-271115-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000119312526271115/d100115d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-26-271115 - JSON: https://secwatch.observer/filing/0001193125-26-271115.json - Plain text: https://secwatch.observer/filing/0001193125-26-271115.txt ## Key facts - Debt Financings ACCENDRA HEALTH INC/VA/ incurred senior notes of $698.0 million aggregate principal amount of Second Lien Notes with Regions Bank (as trustee) at 9.750% per year maturing June 15, 2033. - Instrument: senior notes - Principal: $698.0 million aggregate principal amount of Second Lien Notes - Counterparty: Regions Bank (as trustee) - Rate: 9.750% per year - Maturity: June 15, 2033 - Event: incurrence source text: On June 15, 2026 (the “Early Settlement Date”), the Company issued (i) $213.0 million in aggregate principal amount of First Lien Notes and (ii) $698.0 million in aggregate principal amount of Second Lien Notes, in exchange for the validly tendered and accepted Early Tendered Notes, and issued $326.25 million in aggregate principal amount of First Lien Notes in the new money issuance, for a total of $539.25 million First Lien Notes. evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312526271115/0001193125-26-271115-index.htm - Debt Financings ACCENDRA HEALTH INC/VA/ amended senior notes of $363,000 aggregate principal amount of 2029 Notes with the trustee of the Existing Notes Indentures at 4.500% maturing 2029. - Instrument: senior notes - Principal: $363,000 aggregate principal amount of 2029 Notes - Counterparty: the trustee of the Existing Notes Indentures - Rate: 4.500% - Maturity: 2029 - Event: amendment source text: On June 9, 2026 the Company entered into supplemental indentures to the Existing Notes Indentures (the “Existing Notes Supplemental Indentures”) to effectuate the Amendments. evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312526271115/0001193125-26-271115-index.htm - Debt Financings ACCENDRA HEALTH INC/VA/ amended senior notes of $4,257,000 aggregate principal amount of 2030 Notes with the trustee of the Existing Notes Indentures at 6.625% maturing 2030. - Instrument: senior notes - Principal: $4,257,000 aggregate principal amount of 2030 Notes - Counterparty: the trustee of the Existing Notes Indentures - Rate: 6.625% - Maturity: 2030 - Event: amendment source text: On June 9, 2026 the Company entered into supplemental indentures to the Existing Notes Indentures (the “Existing Notes Supplemental Indentures”) to effectuate the Amendments. evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312526271115/0001193125-26-271115-index.htm - Debt Financings ACCENDRA HEALTH INC/VA/ incurred senior notes of $539.25 million aggregate principal amount of First Lien Notes with Regions Bank (as trustee) at 9.000% per year maturing June 15, 2032. - Instrument: senior notes - Principal: $539.25 million aggregate principal amount of First Lien Notes - Counterparty: Regions Bank (as trustee) - Rate: 9.000% per year - Maturity: June 15, 2032 - Event: incurrence source text: On June 15, 2026 (the “Early Settlement Date”), the Company issued (i) $213.0 million in aggregate principal amount of First Lien Notes and (ii) $698.0 million in aggregate principal amount of Second Lien Notes, in exchange for the validly tendered and accepted Early Tendered Notes, and issued $326.25 million in aggregate principal amount of First Lien Notes in the new money issuance, for a total of $539.25 million First Lien Notes. evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312526271115/0001193125-26-271115-index.htm - Material Agreements ACCENDRA HEALTH INC/VA/ entered into New Notes Indentures (First Lien Indenture and Second Lien Indenture) with Regions Bank valued at First Lien Notes bear interest at 9.000% per year; Second Lien Notes bear interest at 9.750% per yea (effective 2026-06-15). - Action: entry - Agreement: notes offering - Counterparty: Regions Bank - Value: First Lien Notes bear interest at 9.000% per year; Second Lien Notes bear interest at 9.750% per yea - Effective: 2026-06-15 source text: The First Lien Notes issued as part of the new money issuance and delivered in exchange for the 2029 Notes tendered prior to the Early Exchange Time were issued pursuant to the Indenture, dated June 15, 2026 (the “First Lien Indenture”), by and among the Company, the guarantors named therein and Regions Bank, as trustee (in such capacity, the “First Lien Trustee”) and as collateral agent (in such capacity, the “First Lien Collateral Agent”) and the Second Lien Notes delivered in exchange for the Early Tendered Notes were, and any Second Lien Notes delivered in exchange for any remaining Existing Notes that are validly tendered in the Exchange Offers following the Early Exchange Time and at or prior to the Expiration Time will be, issued pursuant to the Indenture, dated June 15, 2026 (the “Second Lien Indenture” and, together with the First Lien Indenture, the “New Indentures”), by and among the Company, the guarantors named therein and Regions Bank, as trustee (in such capacity, the “S evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000119312526271115/0001193125-26-271115-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.